Breast cancer incidence and mortality by metabolic syndrome and obesity: The Women's Health Initiative.
Rowan T ChlebowskiAaron K AragakiKathy PanMichael S SimonMarian L NeuhouserReina HaqueThomas E RohanJean Wactawski-WendeTonya S OrchardJoanne E MortimerDorothy LaneAndrew M KaunitzPinkal DesaiRobert A WildAna BaracJoAnn E MansonPublished in: Cancer (2024)
MetS and obesity status have independent, but differential, adverse associations with breast cancer receptor subtypes and breast cancer mortality risk. Both represent separate targets for breast cancer prediction and prevention strategies.
Keyphrases
- metabolic syndrome
- insulin resistance
- type diabetes
- weight loss
- breast cancer risk
- public health
- risk factors
- mental health
- polycystic ovary syndrome
- emergency department
- weight gain
- adipose tissue
- cardiovascular events
- cardiovascular disease
- high fat diet induced
- coronary artery disease
- young adults
- quality improvement
- health information
- health promotion
- adverse drug
- binding protein
- childhood cancer